RAPT
USDRAPT Therapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$28.550
고가
$29.605
저가
$28.190
거래량
0.43M
기업 기본 정보
시가총액
708.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.36M
거래소
NGM
통화
USD
52주 범위
관련 뉴스
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing
Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $72
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics with a Overweight and raises the price target from $48 to $72.
HC Wainwright & Co. Maintains Buy on RAPT Therapeutics, Raises Price Target to $72
HC Wainwright & Co. analyst Emily Bodnar maintains RAPT Therapeutics with a Buy and raises the price target from $27 to $72.
Guggenheim Initiates Coverage On RAPT Therapeutics with Buy Rating, Announces Price Target of $70
Guggenheim analyst Yatin Suneja initiates coverage on RAPT Therapeutics with a Buy rating and announces Price Target of $70.
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT) ("RAPT"), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and
Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $48
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics with a Overweight and raises the price target from $38 to $48.
Barclays Maintains Overweight on RAPT Therapeutics, Raises Price Target to $58
Barclays analyst Etzer Darout maintains RAPT Therapeutics with a Overweight and raises the price target from $35 to $58.
